Purine nucleosides have been reported to extend the preservation of red cells stored in acid citrate dextrose (ACD) (1-6). This effect was originally attributed to the production of phosphorylated ribose as an energy substrate within the erythrocyte (7-9) through the action of nucleoside phosphorylase (10). This enzyme was shown to act on inosine, guanosine (11, 12) , and on adenosine after its conversion to inosine by the adenosine deaminase of the erythrocyte (3, 13-19). Since inosine was the preferred substrate over guanosine ( 11 ) and was much less toxic than adenosine (2, 3, 16, 18, 20) , it was selected as the most suitable of the nucleosides for red cell preservation. Indeed, the initial studies indicated that inosine produced satisfactory preservation for 42 days and was even more effective than adenosine in regenerating depleted organic phosphate esters in erythrocytes stored for 25 days (3, 11).
tions used. Secondly, unexpected differences occurred in studies comparing various nucleosides. Red cell viability was better maintained with adenosine than with inosine (6) , and adenosine was more effective than inosine in maintaining and regenerating adenosine triphosphate (ATP) in the stored cells (6, 21, 22) . Finally, the importance of the purine moiety of the nucleosides was emphasized by reports of net synthesis of adenine nucleotide occurring after incubation of nucleotide-depleted cells with adenosine or with inosine (22) (23) (24) (25) (26) .
Recently, Nakao and his associates reported an effect of adenine on stored cells (27, 28) . When blood which had been previously stored for 8 to 10 weeks was incubated with both adenine and inosine, the altered red cell appearance reverted to normal or near normal and regeneration of ATP took place. These changes did not occur when the incubation medium contained either inosine or adenine alone. Furthermore, when the ACD preservative was supplemented with both inosine and adenine at the beginning of storage, red cell shape, osmotic resistance, ATP and post-transfusion viability were better maintained than in samples supplemented with inosine alone or not supplemented at all (29, 30) .
The present studies are concerned with the action of adenine alone on post-transfusion viability and on biochemical alterations of erythrocytes during storage. The results indicate that small amounts of this purine base are more effective than large supplements of inosine in the preservation of red cell viability.
MATERIALS AND METHODS
Purine compounds. Adenine (lot no. AN 6001) and inosine (lot no. I0 5802) were obtained from Schwarz BioResearch, Inc., and adenine sulfate (lot no. A89-70) from the Sigma Chemical Company. These compounds were examined by ascending paper chromatography using a) distilled water, b) n-butanol: 4 per cent boric acid (86: 14) , and c) n-butanol: HO (86:14) as solvent systems (31) . Sufficient material was spotted to detect 0.5 to 1.0 per cent hypoxanthine in adenine, or 0.5 to 1.0 per cent adenine, adenosine, or hypoxanthine in inosine. Ultraviolet-absorbing impurities were not found. Chromatography of the adenine sulfate, in quantities sufficient to detect small contaminants, resulted in streaking and thus proved unsatisfactory; its spectral reference ratios were 0.76 at A 250/260, 0.35 at A 280/260, and 0.02 at A 290/260, which conformed to accepted values (32) .
Solutions of adenine, adenine sulfate, and inosine were prepared in concentrations of 0.02, 0.02, and 0.15 M, respectively, in 0.15 M NaCl. When larger amounts of adenine were required, the purine was dissolved first in 1 N HCl and adjusted to pH 6.5 with 1 N NaOH, resulting in a final concentration of 0.045 M adenine in 0.36 M NaCl. All solutions were sterilized through Morton ultrafine fritted Pyrex filters. The concentrations of adenine and inosine were calculated by their absorption at 262 mA (AmM 13.1, pH 1) and 248 mlu (AmM 12.2, pH 6), respectively (32 Measurement of erythrocyte glycolysis in the presence of methylene blue. Blood was centrifuged for 5 minutes at 1,800 G in the International refrigerated centrifuge, model PR-2, at 40 C, and the cells were washed with 8 vol of cold 0.15 M NaCl, centrifuged as above, and resuspended, with continuous mixing, in 2 vol of cold 0.3 M glycine-KOH buffer, pH 9.0. After the suspension was kept at room temperature for 10 minutes to allow pH equilibration, centrifugation was repeated, and the supernatant fraction was removed. The final cell suspension was prepared by the addition of 8 ml of isotonic saline-phosphate buffer (0.075 M sodium chloride-0.04 M potassium phosphate), pH 8.0, containing 130 ,umoles of glucose, to 4 ml of red cells. The reactions were stopped and the C140 released from solution by injecting 4.0 ml of 0.6 N perchloric acid through the rubber stopper. Immediately thereafter, 0.5 ml of hydroxide of Hyamine (36) was injected through the stopper into the center well, and the flasks were shaken in the cold for 80 minutes to insure complete trapping of the CO, by the Hyamine. Finally, the perchloric acid extracts were prepared for glucose and lactate determinations as previously described. The remaining reaction mixture (flask no. 5) was used for hemoglobin, hematocrit, and pH measurements, performed at the beginning and end of the incubation period.
The center wells were flushed into counting vials with 10 ml of reagent grade toluene containing 0. and buffer was incubated and analyzed; no significant radioactivity was released into the Hyamine (37).
Standard methods. Morphologic examinations of the stored cells were performed on smears stained with Wright's stain and on wet preparations suspended in a solution of 1 per cent formalin in 3 per cent trisodium citrate (38) . Total hemoglobin was estimated colorimetrically as cyanmethemoglobin; plasma hemoglobin was measured as pyridine hemochromogen (39) . Measurements of pH on whole blood and incubation mixtures were performed at room temperature with a Beckman model G pH meter and standard glass electrodes.
Glucose was estimated with glucose oxidase (40) and lactate with lactic dehydrogenase (41) . ATP was measured in the bioluminescent reaction with luciferin-luciferase (42) 
RESULTS
In the experiments to be described adenine was added to the ACD-blood at the beginning of the storage period in order to evaluate its effect on: 1) the preservation of post-transfusion viability, In all, 12 samples of blood from 6 donors were supplemented with an optimal level of 0.75 ± 0.25 uAmole of adenine and stored 39 to 46 days; 9 specimens from the same units were stored in In vitro studies General changes. Morphologic studies during storage showed some retardation in the progressive change from biconcave disk -> crenated disk -> crenated sphere -4 microsphere when adenine or adenine plus inosine was present, but quantita-tion of these changes was not undertaken. In the various units studied, the pH was initially 7.1 to 7.2 and declined to values between 6.6 and 6.9 after 6 weeks of storage, without consistent differences related to the type of supplementation.
In vitro hemolysis amounted to about 1 per cent by 6 weeks of storage. It was slightly more with the larger supplements of adenine and somewhat less when inosine was present. Further hemolysis during processing of the cells was appreciable only in those specimens which contained 4 /moles of adenine; the corrections for cell loss through hemolysis required in estimating viability ranged from 1 to 3 per cent.
Chemical changes accompanying storage. The total amount of glucose consumed and lactate formed during the storage period was calculated from the glucose and lactate content of the blood, measured at the beginning and end of the storage period. In each of the units tested (6 experi- The effect of inosine supplementation on glucose consumption and lactate formation throughout storage differed considerably from the adenine effect. Glucose consumption was almost completely inhibited while lactate formation was increased when compared with the ACD controls. In none of the stored samples was glucose consumed completely; at least 9 umoles per ml blood remained in each of the specimens after 6 weeks of storage.
Erythrocyte glycolysis after storage with adenine. The capacity to utilize glucose via glycolysis as well as via the hexose monophosphate shunt pathway and the pentose cycle was measured at the end of the storage period at 370 C in the presence of methylene blue, after the stored cells were washed and their pH was adjusted to a value of 8.0 + 0. (Figure 4 ).
DISCUSSION
The studies reported herein indicate that adenine will improve the preservation of red cells stored at 40 C in ACD. With optimal adenine supplementation the post-transfusion survival of blood stored 39 days (3 donor samples in 6 recipients) was better than 70 per cent. After 42 to 46 days of storage, 62 to 79 per cent of the adenine-supplemented cells survived (samples from 6 donors in 18 recipients). These preliminary studies indicate that the duration of satisfactory storage with adenine is at least 5 weeks.
In vitro measurements also demonstrated the beneficial effect of adenine. The ability of the stored cells to catabolize glucose, when measured at 370 C at the end of the storage period, was much better maintained in red cells stored with adenine than in control cells kept in ACD alone. ATP levels were also higher in the adenine-supplemented samples. While it has been shown that human red cells can incorporate adenine into adenine nucleotides (28, (43) (44) (45) it is not known whether this mechanism was responsible for the effects observed here. In our studies, the effect of adenine on viability was more marked than the (Table II) .
There are stronger resemblances between the present results with adenine and the previous work with adenosine. Not only are the survival data more comparable, but with adenosine, as with optimal amounts of adenine, glucose consumption during storage is well maintained while it is depressed in favor of ribose consumption with inosine (3, 18, 21, 50) . The consistent results obtained with adenosine make contamination a less likely explanation for its effects, but this possibility cannot be completely dismissed. It remains to be determined whether adenosine and adenine share a common underlying mechanism of action.
To date, cleavage of adenosine to adenine has not been demonstrated with human red cells (3, (17) (18) (19) . While significant direct phosphorylation of adenosine to form adenine nucleotides (51) does not appear to occur in rabbit erythrocytes (52, 53) , such data for human red cells have not been reported.
SUMMARY
Supplementing the ACD-preservative with small amounts of adenine (0.75 ± 0.25 .mole per ml ACD-blood) at the beginning of the storage period, preserves satisfactory viability (post-transfusion survival greater than 70 per cent) of stored human erythrocytes for at least 5 weeks. Larger amounts of adenine are less effective. The improved viability is associated with higher intracellular ATP levels throughout storage and better preservation of erythrocyte glycolytic capacity, measured at 370 C at the end of the storage period. The simultaneous addition of relatively large amounts of inosine (10 jtmoles per ml ACD-blood) has little further effect in extending viability. 7 In the studies in which incubation with adenosine resulted in net adenine nucleotide formation (23) (24) (25) (26) ) the magnitude of the increase was such that incorporation into nucleotide of a purine contaminant, which comprised 2 to 6 per cent of the adenosine, could account for the data. In one report (54) the adenosine contained a 10 per cent impurity, having the mobility of adenine or hypoxanthine on paper chromatography. Dr. Mollison has kindly furnished us a sample of the adenosine used in their study (6) . No adenine was found after sufficient adenosine was chromatographed to detect a 0.5 to 1.0 per cent adenine contaminant. However, an ultraviolet-absorbing impurity having the mobility of guanosine was detected [n-butanol: water (86: 14), distilled water] which comprised about 4 to 5 per cent of the material present.
